Exercises Option

Related by string. Exercises Options * EXERCISE . EXERCISES : breathing exercises . shares Warrant Exercise / options . OPTIONS : Option Plan * VP Exercises Options . SVP Exercises Options . EVP Exercises Options . CFO Exercises Options . CEO Exercises Options . Director Exercises Options . COO Exercises Options . Executive Exercises Options . Exec Exercises Options *

Related by context. All words. (Click for frequent words.) 82 Signs Option Agreement 80 Enters Into Agreement 79 Executes Agreement 79 Finalizes Agreement 79 Enters Agreement 79 Closes Sale 79 Increases Ownership 78 Announces Successful Completion 78 Closes Acquisition 78 Announces Definitive Agreement 77 Seeks Approval 77 Signs Definitive Agreement 77 Sign Definitive Agreement 77 Closes Previously Announced 77 Updates Status 77 Announces Initiation 77 Completes Initial 77 Closes Acquisition Of 77 Enters Into Definitive Agreement 77 Signs Agreements 77 Announce Completion 77 Completes Financing 77 Closes Second Tranche 76 Reports Positive 76 Announces Commencement 76 Completes Transaction 76 Receives Conditional Approval 76 Completes Purchase 76 Completes Private Placement 76 Closes Private Placement 76 Secures Financing 76 Provides Updates 76 Announces Termination 76 Closes Financing 76 Announces Cancellation 76 Extends Offer 75 Shareholders Approve Acquisition 75 Provides Operational Update 75 Announces Signing 75 Drilling Underway 75 Renegotiates 75 Completes Drilling 75 Aquires 75 Terminates Agreement 75 Announces Shareholder Approval 75 Announces Private Placement 75 Resumes Drilling 75 Grants Options 74 Completes Purchase Of 74 Amends Agreement 74 Gets Approval 74 Announces Positive 74 Increases Size 74 Enters Into Agreements 74 Receives Milestone Payment 74 Obtains Approval 74 Announce Commencement 74 Provides Clarification 74 Completes Tender Offer 74 IIROC Resume 74 Announces Issuance 74 Begins Drilling 74 Terminates Contract 74 Finalizes Deal 74 Files Shelf Registration Statement 74 Starts Drilling 74 Finalizes Acquisition 74 Completes Acquisition 74 Commence Drilling 74 Consummates 74 Completes Sale 74 Settles Litigation 74 Arranges Financing 74 Receives Approval 74 Announces Effective Date 74 Announces Intent 74 Amends Terms 74 Announces Granting 74 FY# Loss Widens 74 Initiates Clinical Trial 74 Provides Update Regarding 74 Increases Private Placement 73 Identifies Significant 73 Board Authorizes 73 Shareholders Approve Merger 73 Announces Bought Deal 73 Subsidiary Acquires 73 Clarifies Status 73 Announces Proposed Acquisition 73 Signs LoI 73 Extends Tender Offer 73 Commences Drilling 73 Completes Sale Of 73 Withdraws Offer 73 Successfully Completes 73 Inks Pact 73 Announces Completion 73 Private Placement Closed 73 Announces Proposed 73 Completes Previously Announced 73 Receives Conditional 73 Completes Conversion 73 Jointly Announce 73 Terminate Merger Agreement 73 Announces Intention 73 Announce Collaboration Agreement 73 Spins Off 73 Announces Licensing Agreement 73 IIROC Halt 73 Announces Non Brokered 73 Strengthens Balance Sheet 73 Subsidiary Enters 73 Arranges Private Placement 73 Updates Shareholders 73 Signs LOI 73 Announce Agreement 73 Acquire Controlling Interest 73 Completes Successful 73 Acquires Controlling Interest 73 Announces Successful 73 Announce Merger Agreement 73 Completes Asset 73 Achieves Milestone 73 Q3 Loss Narrows 73 Expand Collaboration 73 Reacquires 73 Receives Notification 73 Drilling Commences 73 Acquire Assets 73 Announces License Agreement 73 Commences Phase 72 Completes Redemption 72 Acquires Remaining 72 Announces Underwriters Exercise 72 Terminates 72 Q3 Loss Widens 72 Shares Soar 72 Drilling Completed 72 Signs Agreement 72 Completes Merger 72 Receives Favorable 72 Confirms Significant 72 Secures Funding 72 Signs Joint Venture 72 Shareholders Approve 72 Announces Closing 72 Licenses Novel 72 Acquires Majority 72 Completes Second Tranche 72 Sign License Agreement 72 Signs MOU 72 Completes Due Diligence 72 Initiates Drilling 72 Drilling Continues 72 Announces Acquisition 72 Attains 72 Announces Formation 72 Receives Shareholder Approval 72 Enters Option Agreement 72 Progresses 72 Maintains Strong 72 Q4 Loss Widens 72 Successfully Completes Tender Offer 72 Completes Enrollment 72 FDA Clears 72 Enters Joint Venture 72 Submits Application 72 Commences Drill Program 72 Announces Presentation 72 Signs License Agreement 72 Acquire Majority 72 Ink Deal 72 Announce Joint Venture 72 Closes Merger 72 Drilling Extends 72 Explore Strategic Alternatives 72 Stockholders Approve Merger 72 Spins Out 72 Acquires Exclusive 72 Enter Into 72 Initiates Phase II 72 Wins Approval 72 Inks MOU 72 Reacquire 72 More Than Doubles 72 Successfully Completed 72 Discontinues 72 Signs Definitive 72 Q2 Loss Widens 72 Announces Favorable 72 Successfully Complete 72 Smartstox.com Spotlights 72 Joins OTCQX 72 Completes Merger With 72 Q1 Loss Narrows 72 Increases Stake 72 Receives Positive 72 Commences Exploration 72 Receives Unsolicited 71 Posts Wider Loss 71 Announce Definitive Agreement 71 Receives Regulatory 71 Net Loss Narrows 71 Announce Receipt 71 Announce Licensing Agreement 71 Subsidiary Signs 71 Q2 Loss Narrows 71 Shows Promise 71 Announces Divestiture 71 Raises Bid 71 Net Loss Widens 71 Announces Normal Course 71 Expands Scope 71 Inks Deal 71 Announce License Agreement 71 Expand Relationship 71 Receives Confirmation 71 Drilling Resumes 71 Announce Collaboration 71 Finalizes Purchase 71 Finalizes 71 Jumps Higher 71 Signs Licensing Agreement 71 Sweetens Bid 71 Sign Licensing Agreement 71 Significantly Expands 71 Acquires Assets 71 Completes Expansion 71 Reduces Debt 71 Commences Operations 71 Sells Stake 71 Recommences 71 Exercises Warrants 71 Announce Signing 71 Acquire Remaining 71 Signs Lease 71 Mutually Agree 71 Completes Non Brokered 71 Voluntarily Withdraw 71 Announces Postponement 71 Enters LOI 71 Announces Organizational Changes 71 Successfully Closes 71 Ups Stake 71 Adopts Shareholder Rights 71 Announces Operational Update 71 Completes Patient Enrollment 71 Reports Assay Results 71 Completes Recapitalization 71 Enters Negotiations 71 Closes Private Placements 71 Receives Patent 71 Announces Debt Settlement 71 Receives Orphan Drug Designation 71 Submits Proposal 71 Ups Bid 71 Option Exercised 71 Repositions 71 Receives Clearance 71 Secures Additional 71 Forms Joint Venture 71 Announces Revised 71 Successfully Tests 71 Retains Investor Relations 71 Receives Notice 71 Redeems 71 Provides Update 71 Enters Into Negotiations 71 Announces Redemption 71 Nears Completion 71 Q2 Profit Rises 71 Announces Preliminary 71 Acquires 71 Announces Receipt 71 BayStreet.ca Research Alert 71 Q4 Loss Narrows 71 Reaches Agreement 71 Expects Higher 70 Q3 Profit Surges 70 Negotiates 70 Shares Surge 70 Reaffirms Commitment 70 Previously Announced 70 Files Patent Application 70 Q1 Loss Widens 70 Monetizes 70 Private Placement Oversubscribed 70 Significantly Increases 70 Secures Contract 70 Restructures 70 Commences Tender Offer 70 Q4 Profit Surges 70 Amend Merger Agreement 70 Q1 Profit Surges 70 Boosts Stake 70 Q2 Profit Soars 70 Successfully Concludes 70 Sells Shares 70 Equity Stake 70 Sinks Lower 70 Commences Production 70 Acquirer Company 70 Q2 Profit Surges 70 Remains Neutral 70 Rated Speculative Buy 70 Has Commenced 70 Files Preliminary Prospectus 70 Amends Private Placement 70 Closes Non Brokered 70 Announces Resumption 70 Receive Milestone Payment 70 Extends Mineralization 70 Signs Purchase Agreement 70 Jointly Develop 70 Announces Filing 70 Present Preclinical Data 70 Achieves Positive 70 Announces Stockholder Approval 70 Closes Flow Through 70 Complete Merger 70 Enters Into Definitive 70 Announces Recapitalization 70 Finalizes Sale 70 Signs Binding Letter 70 Withdraws Proposal 70 Completes 70 BioSante Pharmaceuticals Announces 70 Presents Preclinical Data 70 Enters Into Option Agreement 70 Obtains License 70 Shareholders Approve Arrangement 70 Commercializes 70 Commences Drilling Program 70 Acquire Stake 70 Commences 70 Grants Incentive 70 Submits Biologics License Application 70 Board Unanimously Rejects 70 FY# Loss Narrows 70 Drug Candidate 69 Receives Favorable Ruling 69 Receives Permit 69 Stock Soars 69 Q4 Profit Plunges 69 Raises Stake 69 Reveals Positive 69 Announces Additions 69 Forges Ahead 69 Commences Drilling Operations 69 Restructures Debt 69 Concludes Acquisition 69 Posts Higher 69 Completes Reverse Merger 69 Finalizes Sale Of 69 Withdraws Application 69 Initiates Clinical 69 Expands Portfolio 69 4Q Loss Widens 69 Mails Offer 69 Annouces 69 Evaluate Strategic Alternatives 69 Signs Contract 69 Shares Climb 69 Extends Term 69 Stays Neutral 69 Makes Significant 69 Commences Trading 69 Presents Positive 69 Undertakes 69 Outbids 69 Subsidiary Wins 69 Announces Consummation 69 Submits Bid 69 Arranges 69 Accepts Offer 69 Signs Memorandum 69 Enters Into Letter 69 Q1 Profit Declines 69 Takeover Speculation 69 Awarded Contracts 69 Enters Into 69 Subsidiary Completes 69 Warrants Exercised 69 Signs Letter 69 Shares Plummet 69 Enrolls First 69 Q4 Profit Rises 69 Achieves Significant 69 Announces Refinancing 69 Reports Receipt 69 Announcement Regarding 69 Moves Towards 69 Snaps Up 69 Receives Notice From 69 &Amp; 69 Files IND 69 Updates Guidance 69 Strikes Deal 69 Signs Pact 69 Announces Publication 69 Majority Stake 69 Announces Definitive Agreements 69 Declares Quarterly Dividends 69 Extends Maturity 69 Completes Divestiture 69 Initiates Enrollment 69 Re Affirms 69 Results Confirm 69 Signs Definitive Agreements 69 Receives FDA Clearance 69 Issues Clarification 69 Reactivates 69 Announce Settlement 69 Flamel Technologies Announces 69 Corporation Announces Pricing 69 Receives Approvable Letter 69 Formalizes 69 Celebrates Opening 69 Strengthens Its 69 Files NI #-# 69 Miraculins Announces 69 Wins Contract 69 Makes Bid 69 Announces FDA Clearance 69 Finalises 69 Shareholder Opinions 69 Increases Non Brokered 69 Reconfirms 69 Reclassifies 69 Q4 Profit Declines 69 Positive Results 69 Obtains 68 Collaborators Present 68 Announces Discontinuation 68 Earnings Scorecard 68 Provides Shareholder 68 Provides Guidance 68 Scoops Up 68 Drilling Confirms 68 Terminate Agreement 68 Directors Authorizes 68 Begins Tender Offer 68 Sees Higher 68 Clears Path 68 Earnings Decline 68 Q3 Profit Declines 68 Q3 Profit Rises 68 Quaterra Announces 68 Enters Definitive Agreement 68 Commence Trading 68 UBS Downgrades 68 Completes Acquisitions 68 Disposes 68 Copper Mineralization 68 Provides Preliminary 68 Approve Merger 68 Acquire 68 Inks Deal With 68 Reaches Definitive Agreement 68 Signs Merger Agreement 68 Newly Acquired 68 Hits Milestone 68 Announces Departure 68 Mobilizes Drill 68 Enters Into Joint Venture 68 Concludes Successful 68 Hana Mining Announces 68 Settles Dispute 68 Q1 Profit Rises 68 Receives Positive Results 68 Closes Oversubscribed 68 Files Revised 68 Initiates Phase 68 Remains Committed 68 Announces Cash Dividend 68 Posts Strong 68 Completes Refinancing 68 Private Placement Financing 68 Announces Repurchase 68 Loss Widens 68 3Q Profit Rises 68 L.P. Announces 68 Closes Buyout 68 Announces Record Date 68 Acquires Remaining Interest 68 Receives Fast Track 68 Delineates 68 Nears Deal 68 Identifies Potential 68 Strengthens Position 68 Initiates Dosing 68 Asset Swap 68 Receives Funding 68 Secures Long Term 68 Releases Second Quarter 68 Crowflight Announces 68 3Q Profit Surges 68 Outlines Strategy 68 Corp. Joins OTCQX 68 Q2 Profit Declines 68 Extends Collaboration 68 Q1 Profit Soars 68 Increase Stake 68 Awarded Contract 68 Underwriters Exercise 68 Quadruples 68 Holders Approve 68 Signs Long Term 68 Settle Patent Dispute 68 Receives Commitment 68 1st Writethru 68 Earnings Soar 68 Discloses 68 Announces Addition 68 Develop Novel 68 Trading Halt 68 FDA Okays 68 Buy Privately Held 68 Signs Deal 68 Assets Acquirer Company 68 Raises Dividend 68 Engages Investor Relations 68 CORRECTION FROM SOURCE 68 Q2 Adj 68 Recieves 68 Releases Third Quarter 68 Q1 Profit Plunges 68 Receives Notice Regarding 68 Finalizes Contract 68 Sign Pact 68 Terminates Merger Agreement 68 Files Shelf Registration 68 Announces Expansion 68 Begins Dosing 68 Shareholder Sues 68 Settles Dispute With 68 Announces Adjournment 68 Terminates Option 68 Announces Expiration 68 Regains Compliance With 68 Enters Into Merger Agreement 68 More Than Triples 68 Finalize Agreement 68 Confirms Commitment 68 Intersects 68 Announces Early Termination 68 TriCo Bancshares Announces 68 Mln Shares 68 Posts Wider 68 Considers Selling 68 Gets Nod 68 Nearing Completion 68 Lupus Drug 68 Extends Contract 68 Announces Share Repurchase 68 Sells Portion 68 Announces Resignation 68 Boosts Dividend 68 Develops Innovative 68 Receives Permission 67 Temporarily Suspends 67 Takes Steps 67 News Unternehmensnachrichten 67 Enters Into LOI 67 Further Strengthens 67 Momentum Continues 67 Regains Compliance 67 Settle Litigation 67 Irw Press 67 Withdraws Bid 67 Reminds Shareholders 67 Enters Into Exclusive 67 Announces Dividend 67 #.#/Share [002] 67 Confirms Presence 67 Shareholders Overwhelmingly Approve 67 Anounces 67 Seeks Buyer 67 Summarizes 67 4th Qtr Profit Rises 67 Increases Quick Facts 67 Halts Production 67 Successful Completion 67 Medoro Resources Announces 67 Earnings Rise 67 Drug Fails 67 Generates Record 67 Drilling Intersects 67 Exceeds Expectations 67 Announce Merger 67 Announces Assay Results 67 Reprices 67 Obtains Exclusive License 67 Initiates Phase III 67 4Q Profit Drops 67 Subsidiary Receives 67 Closes Over Allotment 67 Amends Credit 67 Reports Profitable 67 Buys Majority Stake 67 Commences Initial 67 CFO Resigns 67 Reaches Settlement Agreement 67 Submits NDA 67 Changes Name 67 Extends Expiration Date 67 Mobilizes 67 Inks Agreement 67 Shareholders Approve Sale 67 Final Stages 67 Completes Transition 67 Declares Distribution 67 Ups Dividend 67 Posts Lower 67 Enlarges 67 Bodes Well 67 Univest Corporation Declares 67 Pursues 67 Q2 Profit Slips 67 1Q Profit Surges 67 Signs Definitive Merger Agreement 67 Regains Full 67 Expands Capabilities 67 Announce Expiration 67 Fully Subscribed 67 Hostile Bid 67 Files Patent 67 Taglich Brothers Initiates Coverage 67 Mulls Sale 67 Misses Estimate 67 Underwriters Exercise Over Allotment 67 Well Positioned 67 Billion Update3 67 NYMH Announces 67 FFO Rises 67 4Q Profit Surges 67 Refocuses 67 Completes Buyout 67 Confirms Receipt 67 Swings To 67 Engages CHF Investor Relations 67 4Q Loss Narrows 67 Minority Stake 67 Finalizes Joint Venture 67 Buys Stake 67 Alert Technicals Showing Bullish 67 Moves Forward 67 Enters Into Strategic 67 Q4 Profit Soars 67 Restate Financial 67 Awaits Approval 67 Earns Milestone Payment 67 Achieves Record Sales 67 Files Definitive Proxy 67 Technicals Showing Bearish 67 Expands Relationship 67 1Q Profit Falls 67 Winning Streak Continues 67 Collaborates With 67 Files Amended 67 Sign Definitive Merger 67 Earnings Climb 67 Second Quarter Profit Rises 67 Subsidiary Awarded 67 Q3 Profit Soars 67 Options Activity 67 Intersects Significant 67 Pacific Rubiales Announces 67 Affirms Commitment 67 Receives Authorization 67 Largest Shareholder 67 Posts Profit 67 Discovers Significant 67 Commences Consent Solicitation 67 Awarded Patents 67 Obtains Financing 67 Doubles Size 67 Settles Lawsuits 67 Widens Quick Facts 67 Reach Agreement 67 Lowers Forecast 67 Reports Preclinical Data 67 Takes Stake 67 Agreement Reached 67 Gold Intersects 67 Announces Dismissal 67 Declares Force Majeure 67 Announces Expanded 67 Obtains Extension 67 Shrs 67 Acquires Majority Stake 67 Posts Solid 67 Acquire Remaining Interest 67 Forges Partnership 67 Mln Common 67 StockSource.us Reports 67 Exclusive License 67 Bulks Up 67 Reaches Milestone 67 Q1 Adj 67 Improves Survival 67 CRWEWallstreet.com Stock Report 67 Receives Regulatory Approvals 67 Break Ground 67 Delivers Strong 67 Daytradersdigest.com 67 Backs FY# Outlook 67 Posts Narrower Loss 67 Licensing Pact 67 Significant Increase 67 Beefs Up 67 Announce Formation 67 Subsidiary Enters Into 67 Announce Successful Completion 67 Inks Contract 67 Oceaneering Announces 67 Jointly Explore 67 Settle Patent Litigation 67 Bearish Speculation 67 Sees Strong 67 Profit Doubles 67 Resumes Production 67 Receives Order 67 Bullish Speculation 67 Sell Stake 66 Stockholders Approve 66 Maintains Buy Rating 66 Million Financing 66 Announces Tender Offer 66 Increases Quarterly Cash Dividend 66 Shareholders Approve Plan 66 Its Previously Announced 66 Provides Updated 66 Shows Promising 66 Restate Financials 66 Coverage Initiated 66 Initiates Clinical Trials 66 Lowers Guidance 66 Announces Restatement 66 ValuEngine Upgrades 66 Study Demonstrates 66 Expands Relationship With 66 Delist From 66 Positions Itself 66 Announces Reverse Split 66 Third Consecutive 66 Results Disappoint 66 Commercialize 66 Confirms 66 Solidifies 66 Lowers Price 66 Executes Letter 66 3Q Loss Widens 66 Gets Clearance 66 Ink Pact 66 Director Exercises Options 66 Finalize Deal 66 Announce Early Termination 66 Extends Reach 66 Inter Citic Releases 66 Expands Mineralization 66 Lowers Outlook 66 Holds Annual Meeting 66 Declares Increase 66 1Q Loss Widens 66 Calls Purchased 66 Announces Sponsorship 66 HSR Waiting Period 66 Posts 2Q 66 Completes Integration 66 Posts 4Q 66 Announce Intention 66 Submits Response 66 Receives NASDAQ 66 Unsolicited Tender Offer 66 Doubles Capacity 66 3Q Profit Up 66 Technicals Showing Bullish 66 Unsolicited Proposal From 66 Announces Mailing 66 Declares Increased 66 Q2 Profit Plunges 66 Upside Potential 66 Realigns 66 Commences Cash 66 Narrows Guidance 66 Proposed Buyout 66 Rebrands 66 Boosts Outlook 66 Announces 66 Enters Into License Agreement 66 Continues Expansion 66 Earnings Postmortem 66 Announces Stock Repurchase 66 Enters Into Licensing Agreement 66 Revenues Decline 66 Sees Positive 66 Shares Plunge 66 4Q Profit Rises 66 Guides Inline 66 1Q Loss Narrows 66 Revises Guidance 66 Buy Stake 66 Reach Settlement 66 Buyout Offer 66 Resubmits 66 Issues Guidance 66 Licensing Deal 66 Pending Acquisition 66 Expands Capacity 66 Boosts Buyback 66 Fancamp Announces 66 ISS Recommends 66 Partners Invests 66 Awarded Prestigious 66 Shareholders Elect 66 Has Received 66 Celebrates Successful 66 Alert Technicals Showing Bearish 66 Restates 66 Nearly Triples 66 FTC Clears 66 Q2 Profit Climbs 66 Provides Operational 66 Files Formal 66 Sees Significant 66 Broadens Its 66 Acquire Majority Stake 66 Controlling Stake 66 Completes Qualifying Transaction 66 Posts 4Q Loss 66 Sweetens 66 Welcomes Analyst Initiation 66 KB Home Swings 66 Review Initiated 66 Posts Record 66 Significantly Expand 66 NewsBite Downgrade Puts Pressure 66 Unveils Latest 66 Sells Remaining 66 Awarded Patent 66 Officially Opens 66 PPD Declares 66 Authorizes Additional 66 Seek Shareholder Approval 66 Ramps Up 66 Unloads 66 4Q Profit Jumps 66 3Q Profit Jumps 66 Key Milestones 66 Restructures Operations 66 Moves Into 66 Shareholders Reject 66 Profit Climbs 66 Cites Positive 66 Recommence 66 Billion Update1 66 Initiates Exploration 66 Announces Appointment 66 Cuts Costs 66 Helps Lift 66 Beats Expectations 66 Files Annual Report 66 Subsidiary Completes Acquisition 66 Executes Definitive Agreement 66 Welcomes Analyst 66 Bullish Technical Alert 66 Beats Estimates 66 Sell Portion 66 Completes Restructuring 66 Establish Joint Venture 66 Announces Affiliation 66 Receives Prestigious 66 Oroco Announces 66 Sell Itself 66 Announces Stock Buyback 66 Becomes Latest 66 Reiterates Buy Rating 66 Enter Into Definitive 66 Declares Second Quarter 66 Losing Streak Continues 66 Exploring Strategic Alternatives 66 Moving Average Crossover Alert 66 VP Exercises Options 66 Shareholder Claims 66 Elevates 66 Outshines 66 Increases Dividend 66 2Q Profit Up 66 Sells Itself 66 Profit Increases 66 Loss Narrows 66 Announce Initiation 66 Million Private Placement 66 Revitalizes 66 Reaches Deal 66 Trims Loss 66 Near Surface 66 4Q Profit Soars 66 Delays Filing 66 Marks Milestone 66 Sharpens Focus 66 Volume Spikes 66 Hikes Dividend 66 Stays Hot 66 Targets Identified 66 Announces Ticker Symbol 66 Q3 Profit Drops 66 Outlines Plans 66 1st Quarter Results 66 Profits Rise 66 3Q Profit Down 66 Bearish Pressure Building 66 Q1 Profit Drops 66 Q3 Profit Plunges 66 Attracts Attention 66 Kirrin Resources Announces 66 Movers Roundup 66 Engages 66 Drill Targets 66 Commences Offering 66 Announces Pricing 65 Plans Buyback 65 Milestone Achieved 65 Acquire Remaining Shares 65 3Q Loss Narrows 65 Introduces Enhanced 65 Signs Definitive Deal 65 Files Petition 65 Important Milestone 65 Previously Announced Private Placement 65 Buys Into 65 Fortifies 65 Files Registration Statement 65 Additional Assay Results 65 Beat Estimates 65 Shrs Rise 65 Restate Results 65 Drilling Intercepts 65 Fifth Consecutive 65 Considers Sale 65 Silver Mineralization 65 Arthritis Drug 65 Sets Record Date 65 Finalizes Purchase Of 65 Announces Appointments 65 Presents Positive Preclinical 65 '5 Rating 65 Moves Closer 65 Receives Approvals 65 Repays 65 Demonstrates Significant 65 Shares Slump 65 Officially Becomes 65 Grants Incentive Stock 65 Beats Consensus 65 Q3 Adj 65 Q2 Profit Drops 65 Profit Beats Estimates 65 Initiates Voluntary Recall 65 Urges Shareholders 65 Ceases 65 Completes Installation 65 Reduces Workforce 65 Announce Partnership 65 Initial Resource Estimate 65 Extend Collaboration 65 Goes Hostile 65 Profit Soars 65 Profit Surges 65 Has Entered 65 Sees Profit 65 Hits Roadblock 65 4Q Profit Down 65 Shareholders Approve Proposed 65 Extends Expiry Date 65 Vantex Completes 65 Bush Embraces Pause 65 Gets FDA Clearance 65 Sells Majority Stake 65 Bullish Engulfing Pattern 65 Furthers 65 Proves Successful 65 Puts Purchased 65 Retracts 65 Beats Forecast 65 Raises PT 65 Fitch Assigns Ratings 65 Draws Attention 65 Posts 3Q Profit 65 Hits Snag 65 Q1 Profit Dips 65 Milestone Payment 65 Successfully Completes Acquisition 65 Beats Forecasts 65 Raise Stake 65 Reaffirms FY# Outlook 65 Registration Statement Declared Effective 65 2Q Profit Rises

Back to home page